61/8013/2026 - Exceptional Use Authorization for Medication

This tender, identified by reference number 61/8013/2026, relates to the 'Exceptional Use Authorization for Medication'. This suggests a process or service related to obtaining special permission to use a specific medication under circumstances not covered by standard approvals or guidelines. This could involve 'compassionate use' programs, off-label use for critical conditions where no alternatives exist, or the procurement of a medication not yet registered or widely available in the country. The objective is likely to facilitate access to essential medicines for patients with severe or life-threatening illnesses who have exhausted conventional treatment options. The tender may be seeking a service provider to manage the application process, liaise with regulatory authorities, or procure the specific medication on behalf of the patient or healthcare institution. The reference number and year (2026) indicate a formal process is being initiated. The successful outcome of this tender will ensure that patients in critical need can access potentially life-saving or life-altering medications through an authorized exceptional pathway, adhering to all necessary protocols and oversight.

This is a supplies contract in the general supplies sector. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 143,904.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.